Clinical trial
Study Comparing Arzoxifene With Raloxifene in Women After Menopause With…
NCT00383422 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00383422 |
|---|---|
| Title | Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis |
| Official title | The Comparison of the Efficacy and Safety of Arzoxifene Versus Raloxifene in Postmenopausal Women With Osteoporosis |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoporosis, Postmenopausal |
| Intervention type | Drug |
| Interventions | Arzoxifene, Raloxifene |
| Enrollment | 320 |
| Start date | Oct 1, 2006 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Oct 3, 2006 |
| Last update posted | Jan 28, 2010 |
| Countries | Argentina, Australia, Canada, France, Italy, Spain, Taiwan, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: